Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A prospective, multicenter study on stem cell mobilization using the EAP regimen as first-line mobilization in patients with multiple myeloma and lymphoma.

Chinese medical journal·2026
Same author

Therapeutic targeting of AREL1 in hepatic stellate cells attenuates MASH-related liver fibrosis.

Nature communications·2026
Same author

Shenfu Injection Inhibits Cardiac Fibroblast Activation and Improves Myocardial Fibrosis by Down-regulating M1 Macrophage-Derived Exosomal miR-155-5p.

Cardiovascular drugs and therapy·2026
Same author

A rare collision tumor of lymphoepithelioma-like carcinoma and t-cell lymphoma: a case report.

Frontiers in oncology·2026
Same author

Laser-induced glare effect and image reconstruction via a frequency-aware transformer.

Optics express·2026
Same author

Knowledge, attitudes, and practices of anesthesiology healthcare professionals regarding crisis resource management in Shanghai, China: a cross-sectional study.

Scientific reports·2026

Related Experiment Video

Updated: Jun 16, 2025

Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

2.6K

Targeted therapy for leukemia based on nanomaterials.

Suying Qian1, Cuiping Zheng2, Yanfang Wu3

  • 1Department of Hematology and Oncology, Ningbo No.2 Hospital, Ningbo, 315000, China.

Heliyon
|August 15, 2024
PubMed
Summary
This summary is machine-generated.

Targeted nanomaterials offer promising leukemia treatment by improving drug delivery and reducing side effects. This review explores advanced organic and inorganic nanomaterials for enhanced leukemia therapy.

Keywords:
LeukemiaNanomaterialsTargeted therapy

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.5K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.4K

Related Experiment Videos

Last Updated: Jun 16, 2025

Biofunctionalization of Magnetic Nanomaterials
06:40

Biofunctionalization of Magnetic Nanomaterials

Published on: July 16, 2020

2.6K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.5K
Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells
10:01

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

6.4K

Area of Science:

  • Oncology
  • Nanomedicine
  • Biomedical Engineering

Background:

  • Leukemia is a malignant hematopoietic stem cell disease with limitations in current drug therapies, including poor bioavailability and significant adverse effects.
  • Targeted therapy is emerging as a mainstream treatment, aiming to selectively eliminate cancer cells while sparing healthy ones.
  • Nanomedicine delivery systems enhance drug efficacy through controlled release and targeted delivery, showing great potential for leukemia treatment.

Purpose of the Study:

  • To provide an overview of current leukemia therapeutic strategies.
  • To review cutting-edge targeted therapeutic nanomaterials for leukemia treatment.
  • To discuss the challenges and future prospects of nanomaterials in leukemia therapy.

Main Methods:

  • Review of current literature on leukemia treatment strategies.
  • Categorization and discussion of organic nanomaterials (carbon-based, lipid, polymers).
  • Categorization and discussion of inorganic nanomaterials (noble metal nanoparticles, magnetic nanoparticles, hollow mesoporous materials).

Main Results:

  • Current drug therapies for leukemia face challenges with bioavailability, adverse reactions, and administration.
  • Targeted therapy and nanomedicine delivery systems show significant promise for improving leukemia treatment outcomes.
  • Both organic and inorganic nanomaterials are being explored for their potential in targeted leukemia therapy.

Conclusions:

  • Nanomaterials offer a promising avenue for developing more effective and safer targeted therapies for leukemia.
  • Further research into the challenges and prospects of these nanomaterials is crucial for clinical translation.
  • Targeted nanomaterial-based strategies hold significant research value and application potential for leukemia treatment.